UBS ASSET MANAGEMENT AMERICAS INC - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 137 filers reported holding ANAPTYSBIO INC in Q4 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$303,901
-17.5%
16,9210.0%0.00%
Q2 2023$368,2010.0%16,9210.0%0.00%
Q1 2023$368,201
-99.9%
16,921
-26.5%
0.00%
Q3 2022$586,908,000
+97.4%
23,007
+57.1%
0.00%
Q2 2022$297,314,000
-47.8%
14,646
-36.3%
0.00%
Q1 2022$569,193,000
-28.8%
23,0070.0%0.00%
Q4 2021$799,494,000
+21.2%
23,007
-5.4%
0.00%
Q3 2021$659,395,000
+4.6%
24,3140.0%0.00%
Q2 2021$630,462,000
+99.8%
24,314
+66.0%
0.00%
Q1 2021$315,621,000
-13.0%
14,646
-13.2%
0.00%
Q4 2020$362,771,000
+45.8%
16,8730.0%0.00%
Q3 2020$248,876,000
-34.0%
16,8730.0%0.00%
Q2 2020$376,943,000
+85.9%
16,873
+17.6%
0.00%
Q1 2020$202,751,000
-94.2%
14,349
-85.6%
0.00%
-100.0%
Q3 2019$3,482,135,000
-39.5%
99,518
-2.5%
0.00%
-50.0%
Q2 2019$5,756,759,000
-19.5%
102,034
+4.3%
0.00%
-20.0%
Q1 2019$7,149,402,000
+19.3%
97,870
+4.2%
0.01%0.0%
Q4 2018$5,992,114,000
-42.1%
93,935
-9.5%
0.01%
-37.5%
Q3 2018$10,350,937,000
+55.6%
103,748
+10.8%
0.01%
+60.0%
Q2 2018$6,652,896,000
-10.5%
93,650
+31.1%
0.01%
-16.7%
Q1 2018$7,437,244,000
+3.5%
71,457
+0.1%
0.01%0.0%
Q4 2017$7,188,790,00071,3740.01%
Other shareholders
ANAPTYSBIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders